JP2022543402A5 - - Google Patents
Info
- Publication number
- JP2022543402A5 JP2022543402A5 JP2022506712A JP2022506712A JP2022543402A5 JP 2022543402 A5 JP2022543402 A5 JP 2022543402A5 JP 2022506712 A JP2022506712 A JP 2022506712A JP 2022506712 A JP2022506712 A JP 2022506712A JP 2022543402 A5 JP2022543402 A5 JP 2022543402A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- perfluorohexyloctane
- isopropanol
- latanoprost
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025129017A JP2025160428A (ja) | 2019-08-09 | 2025-08-01 | プロスタグランジンアナログを含む局所組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19191035.5 | 2019-08-09 | ||
| EP19191035 | 2019-08-09 | ||
| PCT/EP2020/072211 WO2021028328A1 (en) | 2019-08-09 | 2020-08-06 | Topical composition comprising a prostaglandin analogue |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025129017A Division JP2025160428A (ja) | 2019-08-09 | 2025-08-01 | プロスタグランジンアナログを含む局所組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543402A JP2022543402A (ja) | 2022-10-12 |
| JP2022543402A5 true JP2022543402A5 (cg-RX-API-DMAC10.html) | 2023-08-17 |
Family
ID=67587648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506712A Pending JP2022543402A (ja) | 2019-08-09 | 2020-08-06 | プロスタグランジンアナログを含む局所組成物 |
| JP2025129017A Pending JP2025160428A (ja) | 2019-08-09 | 2025-08-01 | プロスタグランジンアナログを含む局所組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025129017A Pending JP2025160428A (ja) | 2019-08-09 | 2025-08-01 | プロスタグランジンアナログを含む局所組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20220362382A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4009952A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2022543402A (cg-RX-API-DMAC10.html) |
| KR (2) | KR20220044739A (cg-RX-API-DMAC10.html) |
| CN (1) | CN114206344A (cg-RX-API-DMAC10.html) |
| AU (2) | AU2020330424A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3144193A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021028328A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6039145B2 (ja) | 2011-05-25 | 2016-12-07 | ノバリック ゲーエムベーハー | 半フッ化アルカンを基礎にした局所薬学的組成物 |
| US20170087100A1 (en) | 2015-09-30 | 2017-03-30 | Novaliq Gmbh | Semifluorinated compounds and their compositions |
| MX381639B (es) | 2016-12-23 | 2025-03-13 | Novaliq Gmbh | Composicion oftalmica para el tratamiento de la enfermedad del ojo seco. |
| CN111182893A (zh) | 2017-10-04 | 2020-05-19 | 诺瓦利克有限责任公司 | 包含f6h8的眼用组合物 |
| AU2019246035B2 (en) | 2018-03-28 | 2024-07-18 | Novaliq Gmbh | Pharmaceutical composition comprising timolol |
| EP3923907B1 (en) | 2019-02-13 | 2024-09-25 | Novaliq GmbH | Compositions and methods for the treatment of ocular neovascularization |
| CN114449999A (zh) | 2019-09-06 | 2022-05-06 | 诺瓦利克有限责任公司 | 用于治疗葡萄膜炎的眼用组合物 |
| IL330080A (en) | 2023-12-19 | 2026-08-01 | Glenmark Specialty S A | A preparation for external use containing dutasteride and lanotrost for the treatment of alopecia |
| AU2025207999A1 (en) * | 2024-01-11 | 2026-07-23 | Glenmark Specialty S.A. | Topical composition comprising clascoterone and latanoprost for alopecia |
| WO2026013128A1 (en) * | 2024-07-10 | 2026-01-15 | Dermaliq Therapeutics, Inc. | Treatment of androgenetic alopecia |
| WO2026104414A1 (en) * | 2024-11-12 | 2026-05-21 | Dermaliq Therapeutics Gmbh | Topical compositions for the treatment of alopecia areata |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69823852T2 (de) | 1997-02-04 | 2005-05-19 | Johnstone, Murray A., Seattle | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems |
| JP2005225817A (ja) * | 2004-02-13 | 2005-08-25 | Jiyugaoka Clinic | 睫毛用育毛剤 |
| US9149484B2 (en) * | 2009-11-09 | 2015-10-06 | Allergan, Inc. | Compositions and methods for stimulating hair growth |
| NZ716349A (en) * | 2009-11-09 | 2017-07-28 | Allergan Inc | Compositions and methods for stimulating hair growth |
| ES2564502T3 (es) * | 2010-03-17 | 2016-03-23 | Novaliq Gmbh | Composición farmacéutica para el tratamiento de la presión intraocular aumentada |
| CN103561724B (zh) * | 2011-05-25 | 2016-06-29 | 诺瓦利克有限责任公司 | 给药给甲的药物组合物 |
| AU2013208002B2 (en) | 2012-01-10 | 2017-11-30 | Allergan, Inc. | Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists |
| EP2944324A1 (de) * | 2014-05-13 | 2015-11-18 | LTS LOHMANN Therapie-Systeme AG | Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen |
| DK3442480T3 (da) * | 2016-06-23 | 2020-01-13 | Novaliq Gmbh | Fremgangsmåde til topisk indgivelse |
| JP7814839B2 (ja) * | 2017-09-27 | 2026-02-17 | ノバリック ゲーエムベーハー | 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物 |
-
2020
- 2020-08-06 JP JP2022506712A patent/JP2022543402A/ja active Pending
- 2020-08-06 WO PCT/EP2020/072211 patent/WO2021028328A1/en not_active Ceased
- 2020-08-06 EP EP20751153.6A patent/EP4009952A1/en active Pending
- 2020-08-06 US US17/634,184 patent/US20220362382A1/en not_active Abandoned
- 2020-08-06 KR KR1020227004324A patent/KR20220044739A/ko not_active Ceased
- 2020-08-06 CN CN202080055661.8A patent/CN114206344A/zh active Pending
- 2020-08-06 AU AU2020330424A patent/AU2020330424A1/en not_active Abandoned
- 2020-08-06 CA CA3144193A patent/CA3144193A1/en active Pending
- 2020-08-06 KR KR1020267011694A patent/KR20260055529A/ko active Pending
-
2025
- 2025-08-01 JP JP2025129017A patent/JP2025160428A/ja active Pending
- 2025-08-26 US US19/310,839 patent/US20260041773A1/en active Pending
-
2026
- 2026-04-07 AU AU2026202586A patent/AU2026202586A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2198476T3 (es) | Inhibidores de no-sintasa. | |
| US20080275118A1 (en) | Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss | |
| US4814351A (en) | Scalp treatment | |
| JP6653342B2 (ja) | 真菌感染症の治療用の局所用オイル組成物 | |
| US20070134175A1 (en) | Panthenol and natural organic extracts for reducing skin irritation | |
| JPH11501941A (ja) | カプサゼピンを含有する局所用組成物 | |
| BRPI1003209A2 (pt) | mÉtodo de tratamento cosmÉtico e sistema de tratamento para tratar o couro cabeludo humano | |
| JP2006515328A (ja) | 哺乳類の発毛の調節 | |
| US5665335A (en) | Combinations of vasoactive substances with fatty acids to prevent hair loss | |
| KR960000855A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물 | |
| CN102048724A (zh) | 用于治疗皮肤的过氧化苯甲酰组合物 | |
| JP2024069595A (ja) | 脱毛防止または毛髪成長促進用の組成物 | |
| KR960010002A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 | |
| BR102017003313A2 (pt) | composição anticaspa e método para a prevenção, redução ou tratamento da caspa | |
| CN111936130B (zh) | 包含锶和甲基磺酰基甲烷(msm)的局部制剂及治疗方法 | |
| KR960010003A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 | |
| JPS61165311A (ja) | 養毛化粧料 | |
| JP2003530420A (ja) | ケラチン物質の化粧処置におけるアルコールデヒドロゲナーゼ阻害剤の使用 | |
| BRPI0900541A2 (pt) | composiÇço de cuidado das fibras queratÍnicas humanas, uso cosmÉtico e processo de tratamento cosmÉtico das fibras queratÍnicas humanas e/ou do couro cabeludo | |
| JP2520700B2 (ja) | 皮膚用の化粧品組成物 | |
| EP4103173A1 (en) | Compositions for treatment of psoriasis of the scalp | |
| CN103732224B (zh) | 用于眼睫毛生长的组合物 | |
| WO1997027837A1 (en) | New chemical mixtures with excellent microbicide, fungicide, and virucide effects; preparation methods, and use | |
| JPWO2013180229A1 (ja) | 育毛用組成物 | |
| JP2004534069A (ja) | No−シンターゼインヒビターとその用途 |